What is the treatment for hives (urticaria)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 17, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hives (Urticaria)

Second-generation non-sedating H1 antihistamines are the first-line treatment for hives (urticaria), with the option to increase the dose up to four times the standard dose for inadequate symptom control. 1

Stepwise Treatment Algorithm

First-Line Treatment: Antihistamines

  • Start with standard doses of second-generation non-sedating H1 antihistamines (cetirizine, desloratadine, fexofenadine, levocetirizine, loratadine, mizolastine) 1, 2
  • Patients should be offered at least two different non-sedating antihistamines, as responses and tolerance vary between individuals 1, 3
  • For inadequate symptom control, increase the dose up to 4 times the standard dose 1, 4
  • First-generation antihistamines should generally be avoided due to sedation effects 3
  • Antihistamines should be used on a regular basis, not only after hives occur 5

Second-Line Treatment: Omalizumab

  • For urticaria unresponsive to high-dose antihistamines, omalizumab (anti-IgE monoclonal antibody) is recommended 6, 7
  • Start with 300 mg every 4 weeks, with the option to increase up to 600 mg every 14 days in patients with insufficient response 6
  • Allow up to 6 months for patients to respond to omalizumab before considering alternative treatments 6
  • Omalizumab is particularly effective for recurrent anaphylaxis and skin symptoms 6

Third-Line Treatment: Cyclosporine

  • For patients who do not respond to high-dose antihistamines and omalizumab 6, 7
  • Effective in about two-thirds of patients with severe autoimmune urticaria at 4 mg/kg daily for up to 2 months 1
  • Regular monitoring of blood pressure and renal function (every 6 weeks) is required due to potential side effects 6
  • Cyclosporine can improve symptoms in approximately 54% to 73% of patients, especially those with autoimmune chronic spontaneous urticaria 7

Management of Anaphylaxis

  • For urticaria with signs of anaphylaxis (hypotension, laryngeal edema, vasomotor collapse, oxygen desaturation, seizures), epinephrine is the first-line treatment 6
  • Systemic hives with no organ involvement can be managed with antihistamines alone 6
  • After epinephrine administration for anaphylaxis, antihistamines and corticosteroids can be added as required 6, 8

Adjunctive Treatments

  • Short courses of systemic corticosteroids (e.g., prednisone) may be used for severe flares until hives resolve 3, 5
  • Most patients respond to doses equivalent to 40 mg of prednisone daily, with the goal of quickly reaching an effective low, alternate-day dose followed by discontinuation 5
  • Cooling antipruritic lotions (calamine or 1% menthol in aqueous cream) can provide symptomatic relief 1, 3

Special Considerations

Renal Impairment

  • Avoid acrivastine in moderate renal impairment 1
  • Halve the dose of cetirizine, levocetirizine, and hydroxyzine in moderate renal impairment 1
  • Cetirizine, levocetirizine, and alimemazine should be avoided in severe renal impairment 1

Hepatic Impairment

  • Avoid mizolastine in significant hepatic impairment 1
  • Avoid alimemazine, chlorphenamine, and hydroxyzine in severe liver disease 1

General Measures

  • Identify and minimize aggravating factors such as overheating, stress, alcohol, and certain medications (aspirin, NSAIDs, codeine) 1, 3
  • NSAIDs should be avoided in aspirin-sensitive patients with urticaria 1
  • ACE inhibitors should be avoided in patients with angioedema without weals 1

Prognosis

  • More than one-half of patients with chronic urticaria will have resolution or improvement of symptoms within a year 4
  • Patient education about the generally favorable prognosis for eventual recovery is important 1

References

Guideline

Urticaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Urticaria.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2024

Guideline

Treatment of Severe Hives (Urticaria)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Acute and Chronic Urticaria: Evaluation and Treatment.

American family physician, 2017

Research

Drug therapy for chronic urticaria.

Clinical reviews in allergy, 1992

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Urticaria and urticaria related skin condition/disease in children.

European annals of allergy and clinical immunology, 2008

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.